 "US Food and Drug Administration")
Galaxy Surfactants dipped 2% to Rs 1,400, extending its past three days 5% decline after the company received Form 483 for two of its facilities in Maharashtra after United States Food and Drug Administration (USFDA) audit.
“The company's two of the facilities (M3 & N46) at Tarapur (Maharashtra) have undergone USFDA inspection which was concluded on March 30, 2018. This is the first USFDA inspection and they issues Form 483 with total 13 observations. The M3 facility received 4 and N46 facility received 9 observations,” Galaxy Surfactants said in a regulatory filing.
All the observations are procedural in
“The company's two of the facilities (M3 & N46) at Tarapur (Maharashtra) have undergone USFDA inspection which was concluded on March 30, 2018. This is the first USFDA inspection and they issues Form 483 with total 13 observations. The M3 facility received 4 and N46 facility received 9 observations,” Galaxy Surfactants said in a regulatory filing.
All the observations are procedural in
